Biblio Discovery — Demo Discovery Service

4 hasil untuk "Kenneth Stier"

Menampilkan 1–4 · 1,31 detik · RSS

  1. Artikel Jurnal

    Research publication trends regarding the extraintestinal manifestations of celiac disease

    Kenneth Stier; Suzanne K. Lewis; Govind Bhagat dkk.

    Informatics in Medicine Unlocked, Vol. 17 · 2019 · Inggris · DOAJ Scopus

    Introduction: Celiac disease (CD) is an autoimmune enteropathy triggered by gluten that has a poor diagnosis rate and a range of extraintestinal manifestations (EIMs), which vary in prevalence. Increasing the rate of diagnosis of, and possibly developing therapies for, CD relies on our…

  2. Artikel Jurnal

    Commercially available glutenases: a potential hazard in coeliac disease

    Suneeta Krishnareddy; Kenneth Stier; Maya Recanati dkk.

    Therapeutic Advances in Gastroenterology, Vol. 10 · 2017 · Inggris · DOAJ Scopus

    Background: The only treatment for celiac disease (CD) is a gluten-free diet (GFD). However, there is interest among patients in a medical therapy to replace or help with a GFD. Therapies include gluten-degrading enzymes (glutenases). There are glutenases available marketed as dietary supplements…

  3. Artikel Jurnal

    gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

    Ellinor Peerschke; Kenneth Stier; Xiaoyu Li dkk.

    Frontiers in Oncology, Vol. 10 · 2020 · Inggris · DOAJ Scopus

    Mesothelioma is an aggressive cancer of the serous membranes with poor prognosis despite combination therapy consisting of surgery, radiotherapy, and platinum-based chemotherapy. Targeted therapies, including immunotherapies, have reported limited success, suggesting the need for additional…

  4. Artikel Jurnal Teks lengkap

    Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

    Emily K. Sims; Brian N. Bundy; Kenneth Stier dkk.

    Science Translational Medicine · 2021 · Inggris · OpenAlex Scopus

    T cell subsets indicated that partially exhausted effector cells were associated with clinical response. Thus, this trial showed improvement in metabolic responses and delay of diabetes with immune therapy.